MarginsXMarginsX
Home › Markets › Health Care › TLPH

Talphera Inc. (TLPH)

TLPH trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.8609
-4.98% on the day
Market cap
$44.7M
Nano cap
Revenue · 2025
$28K
Prior year not contiguous
Net income · 2025
-$14.3M
-51035.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1427925/000143774926009387/0001437749-26-009387-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerTLPH on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2011
SEC CIK0001427925
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$28K
Net income-$14.3M
Operating income-$13.5M
Net margin-51035.7%
Operating margin-48157.1%
Revenue growthNo prior-year revenue to compare
Cash$5.9M
Total assets$29.7M
P/E (computed)Net income was not positive
P/S (computed)1597.5×

Warning signs

Cash runway
10.0 months
$10.7M cash at September 30, 2026
Share count, 1 year
+11.5%
2025-11-05 to 2026-11-04 · +206.5% over 3 years
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$276K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These conditions raise substantial doubt about the Company's ability to continue as a going concern."
10-Q 2026-11-12
Cash and burn$10.7M cash; operating cash flow -$3.2M a quarter.Report 2026-09-30
Shares outstanding51,957,714 (2026-11-04); 46,609,618 a year earlier; 16,952,269 three years earlier.Cover page 2026-11-04
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-11-12
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-03-13
AuditorBPM LLP, Walnut Creek, California, United StatesPCAOB Form AP 2026-03-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $276K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$0-$4.0M-$3.0M$10.7MNo debt tags$010-Q 2026-11-12
Q2 2026
2026-06-30
$0-$4.3M-$3.9M$742KNo debt tags$1K10-Q 2026-08-12
Q1 2026
2026-03-31
$0-$2.6M-$3.4M$3.8MNo debt tags$1K10-Q 2026-05-13
Q4 2025
2025-12-31
$0-$3.8M-$2.4M$5.9MNo debt tags$28K10-K 2026-03-23
Q3 2025
2025-09-30
$1K-$4.4M-$2.5M$3.5MNo debt tags$28K10-Q 2026-11-12
Q2 2025
2025-06-30
$0-$3.5M-$2.9M$6.8MNo debt tags$27K10-Q 2026-08-12
Q1 2025
2025-03-31
$27K-$2.6M-$3.5M$5.4MNo debt tags$27K10-Q 2026-05-13
Q4 2024
2024-12-31
$0-$1.9M-$2.3M$8.9MNo debt tags$010-K 2026-03-23

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3
S-32026-11-12
Latest annual report
FORM 10-K
10-K2026-03-23
Latest quarterly / interim
FORM 10-Q
10-Q2026-11-12
Latest current report
FORM 8-K
8-K2026-11-12
Latest proxy
FORM DEFA14A
DEFA14A2026-04-29

Source: SEC EDGAR submissions feed, 966 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-13.3%
1 month-15.0%
3 months-24.8%
Year to date-20.2%
1 year-13.3%
From 52-week high-38.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
HYFTMindWalk Holdings Corp.$0.9378-8.95%$44.6M
ONCYOncolytics Biotech Inc.$0.3399-8.14%$44.6M
NMADNomad Power Solutions Inc.$2.80+19.15%$45.1M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.3650-29.81%$45.4M
RNXTRenovoRx Inc.$0.9549-8.18%$46.1M
ANVSAnnovis Bio Inc.$0.7500-19.02%$46.5M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M
ATNMActinium Pharmaceuticals Inc. (Delaware)$1.49-9.15%$46.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier